AMITYVILLE, N.Y. & NEWBURY PARK, Calif.--(BUSINESS WIRE)--Topix, an independent leader in skincare with a differentiated portfolio of clinically-proven products and brands sold across the medical and natural channels, today announced the acquisition of ClarityRx, the emerging leader in the professional spa-dispensed skincare market.
Founded in 2003, ClarityRx has a sixteen-year track-record of partnering with the most successful spas and estheticians, including the Hand & Stone network, to deliver differentiated plant-based, results-driven skincare. As part of the Topix family of brands, ClarityRx will benefit from the scale of Topix, one of the largest private skincare companies in the United States, as well as Topix’s three decades of experience in the physician-dispensed and clean beauty markets. Following the transaction, ClarityRx expects to accelerate its investment in new product development as well as its focus on esthetician training and partnership. ClarityRx will continue to be headquartered in Newbury Park, CA and led by Co-Founders Karla Keene and Darcie Crandall.
“Topix’s commitment to furthering the ClarityRx philosophy and mission, while providing us with the resources to enhance our product offering, is the exact partnership that we had envisioned for ClarityRx’s next phase of growth,” commented ClarityRx’s Co-Founders Karla Keene and Darcie Crandall. “We look forward to achieving new heights for ClarityRx in partnership with Topix and continuing to deliver world-class products and services for our customers.”
“We are so excited to welcome Karla, Darcie and the entire ClarityRx team into the Topix family,” said Brenda Wu, Chief Executive Officer of Topix. “ClarityRx is a highly differentiated, modern brand that delivers what today’s discerning consumers are seeking, the best of science and nature. We see tremendous potential in ClarityRx and are eager to further support the brand and their customers, including the over four hundred Hand & Stone franchises.”
“For over thirty-five years, Topix has worked with the leading dermatologists in the U.S., including the largest multi-office practices, to deliver results for their patients while also providing them with the tools to build their own businesses. We look forward to the opportunity to bring the same customer-centric focus to the professional spa market,” added Andre Moura, Managing Director at New Mountain Capital, which has backed Topix since 2016, and Chairman of the Topix Board of Directors.
Stubbs Alderton & Markiles LLP served as legal advisor to ClarityRx while Lowenstein Sandler LLP provided legal counsel to Topix and New Mountain Capital.
Topix is an independent leader in skincare with a differentiated portfolio of clinically-proven products and brands sold across high-growth channels. Topix was founded in 1981 and built its reputation in the physician market where it is the largest provider of premium, micro-branded and branded skincare products, partnering with over 3,000 physicians in the U.S. For more information on Topix, please visit: http://www.topixpharm.com/
Founded in 2003 and headquartered in Newbury Park, California, ClarityRx’s mission is to deliver plant-based, results-driven skincare with no trade-off between safety and efficacy. ClarityRx provides leading, professional-grade skincare products by seamlessly pairing cutting-edge technology with potent natural ingredients. For more information on ClarityRx, please visit: https://clarityclinicalskincare.com
About New Mountain Capital
New Mountain Capital is a New York based investment firm that emphasizes business building and non-cyclical growth, rather than debt, as it pursues long-term capital appreciation. The firm currently manages private equity, public equity, and credit funds with over $20 billion in assets under management. New Mountain seeks out what it believes to be the highest quality growth leaders in carefully selected industry sectors and then works intensively with management to build the value of these companies. For more information on New Mountain Capital, please visit: www.newmountaincapital.com